DeepCare

DeepCare (羽医甘蓝) develops artificial intelligence software for dental imaging analysis and clinical decision support. Founded in Beijing in 2016, the company has built a multimodal AI platform capable of processing panoramic X-rays, CBCT scans, cephalometric images, periapical films, and intraoral photographs to assist dentists with diagnosis and treatment planning.

Company Overview

The company emerged from research collaborations involving alumni from Dartmouth College, UCLA, University of Maryland, Tsinghua University, Peking University, and Zhejiang University. Dr. Peng Ding (also known as Dr. Eric Ding) serves as founder and CEO, while Dr. Hailong Bai co-founded the company as CTO.

DeepCare positions itself at the intersection of computer vision, natural language processing, and dental medicine. Rather than manufacturing physical robotic equipment, the company focuses on AI algorithms that analyze dental images and provide clinical recommendations. This software-centric approach differentiates DeepCare from traditional surgical robot manufacturers in the medical device industry.

The company maintains dual headquarters in Beijing and Los Angeles, reflecting its strategy to serve both Asian and Western markets with localized products and support.

Core Products

Dental AI Platform

The flagship product integrates multiple AI capabilities into a unified clinical workflow system. Key features include:

• Multimodal Image Analysis: Processes seven types of dental images including panoramic X-rays, CBCT volumes, lateral cephalometric films, periapical radiographs, intraoral photos, extraoral photos, and intraoral scans
• Pathology Detection: Identifies nearly 40 dental conditions within seconds, covering caries, periapical lesions, periodontal disease, and restorative status
• Pediatric Dentistry Module: Automatically distinguishes primary and permanent teeth during mixed dentition, simulates tooth development progression, and generates child-friendly animated reports

CBCT AI

Enhanced volumetric imaging analysis features include:

• Cranium segmentation and reconstruction for visualization of anatomical structures such as the mandibular fossa and sphenoid bone
• Automated 3D segmentation of periapical lesions including maxillary sinus abnormalities
• Volume measurement and lesion characterization tools
• Color rendering schemes for improved scan interpretation

Dental ChatBot

A conversational AI interface combining natural language processing with computer vision capabilities:

• Interprets oral health assessment reports for patients
• Provides instant responses to patient questions about dental conditions
• Accepts text, voice, and image inputs
• Recommends appropriate specialists based on clinical findings

Treatment Planning System

AI-assisted design tools for:

• Implant planning with high-precision 3D reconstruction
• Orthodontic treatment simulation
• Surgical guide generation
• Risk assessment and outcome prediction

Technology & Innovation

DeepCare’s AI models are trained on proprietary datasets of standardized dental images annotated and validated by experienced dental specialists. The company emphasizes cross-regional data diversity to ensure algorithm performance across different patient populations.

The platform was selected for Beijing’s inaugural Medical Artificial Intelligence Major Science and Technology Program, providing government support for clinical validation at major dental institutions including Peking University School of Stomatology.

Unlike rule-based diagnostic systems, DeepCare’s AI Agent employs contextual reasoning that considers patient-specific factors such as age, developmental stage, medical history, and financial constraints when generating treatment recommendations.

Strategic Partnerships

Straumann Group

In December 2020, DeepCare announced a strategic partnership with Straumann Group, a global leader in esthetic dentistry. The collaboration aims to integrate AI-powered diagnosis and planning tools into Straumann’s commercial network across China and internationally.

Medit Integration

DeepCare’s platform integrates with Medit Link, the software ecosystem for Medit intraoral scanners. This partnership enables direct data transfer between scanning devices and AI analysis tools, streamlining digital dentistry workflows.

Academic Collaborations

The company maintains research partnerships with Peking University School of Stomatology and collaborates with CareCapital (松柏投资), a dental industry investment group with portfolio companies including Angelalign (时代天使), Neoss implants, and Medit.

Market Presence

As of 2025, DeepCare reports serving tens of thousands of dental clinics and millions of patients across more than 60 countries spanning North America, Europe, East Asia, Southeast Asia, the Middle East, North Africa, and South America. Earlier company statements indicated approximately 5,000 dental institutions using the platform across 11 countries as of 2023.

The company has exhibited at the International Dental Show (IDS) in Cologne, Germany in both 2023 and 2025, demonstrating its AI Agent and upgraded CBCT features to international audiences.

Key Milestones

• 2016: Company founded in Beijing
• 2020: Strategic partnership with Straumann Group announced
• 2020: Completed panoramic X-ray AI analysis functionality
• 2021: Strategic investment from CareCapital
• 2021: Series A funding led by Anand Investment, with participation from CareCapital, Xiaochuan Wang (Sogou founder), and others
• 2023: Debuted at IDS Cologne, launched Dental ChatBot
• 2024: Medit Link integration announced
• 2025: Unveiled Multimodal Dental AI Agent at IDS 2025

Frequently Asked Questions

What products does DeepCare offer?

DeepCare provides AI software for dental imaging analysis rather than physical robotic equipment. Its main products include the Dental AI platform for multimodal image analysis, CBCT AI for volumetric scan interpretation, Dental ChatBot for patient communication, and AI-assisted treatment planning tools for implants and orthodontics.

Does DeepCare manufacture dental robots?

No. DeepCare is a software company specializing in artificial intelligence algorithms for dental diagnosis and treatment planning. The company does not produce physical robotic hardware but instead develops AI that can be integrated into existing dental practice management systems and imaging workflows.

Who invested in DeepCare?

DeepCare’s investors include CareCapital (松柏投资), Anand Investment, Zhongguancun Development Group, Microsoft ScaleUp, and Xiaochuan Wang, the founder of Sogou. Total disclosed funding is approximately $910,000 as of Series A.

How many clinics use DeepCare’s software?

The company reports serving tens of thousands of clinics across 60+ countries as of 2025. Earlier figures from 2023 indicated approximately 5,000 dental institutions across 11 countries and regions.